Evidence map›Paper›PMID 41407924›Full record

ArticleCommunications chemistry2025

Structure characterization with NMR molecular networking.

Cailum M K Stienstra, Jaegun Song, David Healey, Gennady Voronov, Eric Gardner, Abhishek Patel, Venkat Macherla, Christoph A Krettler, Tobias Kind, Pieter C Dorrestein and 1 more

Abstract read
In one paragraph

Article in Communications chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Cailum M K StienstraEnveda Therapeutics, Inc., Boulder, CO, USA.ORCID http://orcid.org/0000-0001-7365-1558
Jaegun SongEnveda Therapeutics, Inc., Boulder, CO, USA.
David HealeyEnveda Therapeutics, Inc., Boulder, CO, USA.ORCID http://orcid.org/0000-0002-9584-9757
Gennady VoronovEnveda Therapeutics, Inc., Boulder, CO, USA.
Eric GardnerEnveda Therapeutics, Inc., Boulder, CO, USA.
Abhishek PatelEnveda Therapeutics, Inc., Boulder, CO, USA.
Venkat MacherlaEnveda Therapeutics, Inc., Boulder, CO, USA.
Christoph A KrettlerEnveda Therapeutics, Inc., Boulder, CO, USA.ORCID http://orcid.org/0000-0002-5709-3864
Tobias KindEnveda Therapeutics, Inc., Boulder, CO, USA.
Pieter C DorresteinSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, CA, USA.ORCID http://orcid.org/0000-0002-3003-1030
Daniel Domingo-FernándezEnveda Therapeutics, Inc., Boulder, CO, USA. daniel.domingo-fernandez@enveda.com.ORCID http://orcid.org/0000-0002-2046-6145

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nuclear Magnetic Resonance (NMR) is among the most widely used techniques for structure determination, yet automated workflows remain underdeveloped compared to mass spectrometry. In this work, we introduce NMR molecular networking and apply it to Heteronuclear Single Quantum Coherence (HSQC) spectra, a key 2D-NMR experiment for structure elucidation. We adapt core principles of MS² networking such as transitivity across multiple spectra, dereplication, and annotation propagation to NMR-driven workflows. First, we develop a modified Hungarian distance metric for HSQC peak matching. Benchmarks show that using this metric, traditional spectral lookup with this score recovers ~70-80% of available structural similarity, but efficiency does not improve when increasing the size of the spectral library. Second, we establish NMR molecular networking using HSQC spectra to propagate annotations and dereplicate compounds. Case studies of experimental natural product spectra demonstrate that annotation transitivity within networks accelerates and improves identification of unknowns. Third, we introduce algorithmic molecular networking, which integrates graph topology metrics to correct inefficient rankings and reduce false positives. Together, these approaches define the first generalizable framework for NMR molecular networking, enabling scalable, high-throughput annotation for natural product discovery and drug development.

Identifiers

PMID41407924
PMCPMC12816106

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.